Amneal Pharmaceuticals recalled 14,923 bottles of Chlorpromazine Hydrochloride Tablets on August 18, 2025. A specific lot of polyester coil used in product packaging tested positive for a micro-organism. No contamination was found in the tablets themselves.
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Consumers and healthcare providers should stop using this product immediately. Contact Amneal Pharmaceuticals, LLC or your healthcare provider for guidance. Notification method: Letter
The recalled product is Chlorpromazine Hydrochloride Tablets, 100 mg in 100-count bottles. The affected lot numbers include AM240334, AM240335, and AM241031. The tablets were distributed nationwide in the USA.
The recall stems from the presence of a foreign substance in the packaging. A specific lot of auxiliary polyester coil tested positive for a micro-organism, posing potential health risks.
No incidents or injuries related to the contamination have been reported. The tablets themselves remain uncontaminated.
Stop using the recalled product immediately. Contact Amneal Pharmaceuticals or your healthcare provider for further guidance.
For more information, call Amneal Pharmaceuticals at 1-800-XXX-XXXX or visit their website at www.amneal.com.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.